초음파치료가 종양세포에 미치는 효과

Effects of Continuous Therapeutic Ultrasound on Subcutaneous Murine Melanoma

The use of therapeutic ultrasound(US) in humans with malignant neoplasms has been contraindicated in Physical therapy Practice. Some studies have shown that results after application of US differ according to tumor type and penetration depth. The purposes of this study were to determine the effects of US on melanoma in mice and to determine treatment dosage. Twenty-four female C57BL/6 mice, age 8 weeks. The right flank of all mice was shaved, and a 0.1 ㎖ suspension of cells was injected subcutaneously into the animals' right flank. In this study, 24 subjects were randomly divided into three groups: experimental group 1(n=8), experimental group 2(n=8), control group(n=8). In the experimental group 1, animals received continuous 3 MHz US treatment, administered at 2.0 W/㎠ for five minutes. In experimental group 2, animals received continuous 3 MHz US treatment, administered at 1.0 W/㎠ for 5 minutes. The control group received the same handing as other experimental groups, including rodent chow, water, US gel application but US head pressure without the power turned on. After 10 days treatment, all mice were killed with a potassium solution. Tumors were excised and weighed on an electrical balance and fixed in a 10% neutral buffered formalin solution. Tumor weights were smaller in experimental group 2(0.3838 g) than in the control group(0.6275 g). Tumor weights of the experimental group 1(0.015 g) were smaller than those of experimental group 2. Continuous therapeutic US decreased the weight of subcutaneous melanoma tumors in mice. The treatment dosage(2.0 W/㎠) we suggest was more effective than earlier studies on decreasing tumor size with ultrasound.